Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marco Rizzi and Ferdinando Lorini.
Marco Rizzi
Connection Strength
0.349
Ferdinando Lorini
  1. Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021 Sep; 35(9):2734.
    View in: PubMed
    Score: 0.060
  2. Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021 09; 35(9):2710-2714.
    View in: PubMed
    Score: 0.059
  3. Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study. BMC Pulm Med. 2021 Mar 20; 21(1):96.
    View in: PubMed
    Score: 0.058
  4. Bergamo and Covid-19: How the Dark Can Turn to Light. Front Med (Lausanne). 2021; 8:609440.
    View in: PubMed
    Score: 0.058
  5. At the peak of COVID-19 age and disease severity but not comorbidities are predictors of mortality: COVID-19 burden in Bergamo, Italy. Panminerva Med. 2021 Mar; 63(1):51-61.
    View in: PubMed
    Score: 0.057
  6. Papa Giovanni XXIII Bergamo Hospital at the time of the COVID-19 outbreak: Letter from the warfront…. Int J Lab Hematol. 2020 06; 42 Suppl 1:8-10.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.